Combination Chemotherapy and Donor Stem Cell Transplant Followed by Ixazomib Citrate Maintenance Therapy in Treating Patients With Relapsed High-Risk Multiple Myeloma
Conditions
- Plasma Cell Leukemia
- Recurrent Plasma Cell Myeloma
Interventions
- PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation
- DRUG: Carmustine
- DRUG: Cytarabine
- DRUG: Etoposide
- DRUG: Ixazomib Citrate
- DRUG: Melphalan
- DRUG: Methotrexate
- PROCEDURE: Peripheral Blood Stem Cell Transplantation
- OTHER: Quality-of-Life Assessment
- DRUG: Tacrolimus
Sponsor
OHSU Knight Cancer Institute
Collaborators